Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated May 13, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 50.3B USD
- Positions
- 290
- Share of the ten largest
- 34.7%
The ten largest positions Q1 2021
- Tesla, Inc. 7.7%▲ +39.9%
- Teladoc Health Inc 5.2%▲ +84.2%
- Block, Inc. 5.0%▲ +55.0%
- Roku Inc 3.2%▼ −7.1%
- Zillow Group Inc 2.6%▲ +54.8%
- Exact Sciences Corp 2.4%▲ +72.2%
- Shopify 2.4%▲ +123.1%
- Baidu (ADR) 2.2%▲ +126.8%
- Spotify Technology SA 2.1%▲ +65.1%
- CRISPR Therapeutics AG 2.0%▼ −20.4%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q1 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| Invitae Corp | 1.8% | 23,977,808 | 916.2M USD | −11.2% reduced | Q4 2016 or earlier 18 quarters |
| Intellia Therapeutics Inc | 1.5% | 9,611,911 | 771.4M USD | −14.1% reduced | Q4 2016 or earlier 18 quarters |
| 2U Inc | 0.9% | 11,837,072 | 452.5M USD | −10.7% reduced | Q4 2016 or earlier 18 quarters |
| Proto Labs Inc | 0.9% | 3,654,854 | 445.0M USD | −11.3% reduced | Q4 2016 or earlier 18 quarters |
| Veracyte Inc | 0.8% | 7,617,287 | 409.4M USD | −15.6% reduced | Q4 2016 or earlier 18 quarters |
| PYPL PayPal | 0.8% | 1,679,629 | 407.9M USD | −35.0% reduced | Q4 2016 or earlier 18 quarters |
| LendingTree Inc | 0.7% | 1,723,091 | 367.0M USD | −14.3% reduced | Q4 2016 or earlier 18 quarters |
| Stratasys Ltd | 0.5% | 10,420,260 | 269.9M USD | −13.8% reduced | Q4 2016 or earlier 18 quarters |
| Materialise NV | 0.5% | 7,441,821 | 267.5M USD | −13.1% reduced | Q4 2016 or earlier 18 quarters |
| Seres Therapeutics Inc | 0.5% | 11,855,947 | 244.1M USD | −13.7% reduced | Q4 2016 or earlier 18 quarters |
| NanoString Technologies Inc | 0.4% | 3,314,947 | 217.8M USD | −15.4% reduced | Q4 2016 or earlier 18 quarters |
| Cerus Corp | 0.3% | 25,541,955 | 153.5M USD | −13.6% reduced | Q4 2016 or earlier 18 quarters |
| Compugen Ltd | 0.2% | 14,422,362 | 123.9M USD | −15.6% reduced | Q4 2016 or earlier 18 quarters |
| NFLX Netflix | 0.1% | 133,501 | 69.6M USD | −35.3% reduced | Q4 2016 or earlier 18 quarters |
| Syros Pharmaceuticals Inc | 0.1% | 7,711,724 | 57.7M USD | −14.7% reduced | Q4 2016 or earlier 18 quarters |
| AMZN Amazon | < 0.1% | 13,918 | 43.1M USD | −38.2% reduced | Q4 2016 or earlier 18 quarters |
| ADBE Adobe Inc. | < 0.1% | 33,165 | 15.8M USD | −69.2% reduced | Q4 2016 or earlier 18 quarters |
| Splunk Inc | < 0.1% | 8,813 | 1.2M USD | −99.6% reduced | Q4 2016 or earlier 18 quarters |
| Editas Medicine Inc | 0.7% | 8,751,923 | 367.6M USD | −13.6% reduced | Q1 2017 17 quarters |
| Cellectis SA | 0.2% | 5,117,526 | 103.4M USD | −23.4% reduced | Q1 2017 17 quarters |
| AAPL Apple Inc. | 0.1% | 594,039 | 72.6M USD | −35.1% reduced | Q1 2017 17 quarters |
| CRISPR Therapeutics AG | 2.0% | 8,290,350 | 1.0B USD | −20.4% reduced | Q2 2017 16 quarters |
| VRSK Verisk Analytics | < 0.1% | 3,588 | 634.0K USD | −95.4% reduced | Q4 2017 14 quarters |
| IBKR Interactive Brokers | < 0.1% | 3,002 | 219.0K USD | −27.0% reduced | Q4 2017 14 quarters |
| SBI Holdings Inc/Japan | < 0.1% | 6,300 | 171.0K USD | −72.6% reduced | Q4 2017 14 quarters |
| AquaBounty Technologies Inc | < 0.1% | 7,247,378 | 48.6M USD | −16.1% reduced | Q1 2018 13 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | < 0.1% | 397,524 | 47.0M USD | −91.2% reduced | Q1 2018 13 quarters |
| Roku Inc | 3.2% | 4,997,644 | 1.6B USD | −7.1% reduced | Q2 2019 8 quarters |
| Personalis Inc | 0.3% | 5,705,827 | 140.4M USD | −15.8% reduced | Q2 2019 8 quarters |
| Arcturus Therapeutics Holdings Inc | 0.3% | 3,331,889 | 137.6M USD | −15.8% reduced | Q2 2019 8 quarters |
| LendingClub Corp | 0.2% | 7,268,414 | 120.1M USD | −2.5% reduced | Q2 2019 8 quarters |
| META Meta Platforms | 0.2% | 307,029 | 90.4M USD | −53.1% reduced | Q2 2019 8 quarters |
| Pluristem Therapeutics Inc | < 0.1% | 3,589,322 | 17.1M USD | −9.3% reduced | Q2 2019 8 quarters |
| Pacific Biosciences of California Inc | 1.4% | 21,301,191 | 709.5M USD | −25.3% reduced | Q3 2019 7 quarters |
| Pinterest Inc | 0.5% | 3,094,949 | 229.1M USD | −49.5% reduced | Q3 2019 7 quarters |
| SNAP Snap | 0.3% | 3,173,955 | 166.0M USD | −4.5% reduced | Q3 2019 7 quarters |
| Meituan | < 0.1% | 2,055 | 161.0K USD | −33.3% reduced | Q4 2019 6 quarters |
| ZS Zscaler | < 0.1% | 621 | 107.0K USD | −98.7% reduced | Q4 2019 6 quarters |
| P Everpure | 1.4% | 32,887,736 | 708.4M USD | −20.1% reduced | Q1 2020 5 quarters |
| PagerDuty Inc | 0.8% | 9,982,602 | 401.6M USD | −13.6% reduced | Q1 2020 5 quarters |
| HUYA Inc | 0.4% | 10,988,392 | 214.1M USD | −5.3% reduced | Q1 2020 5 quarters |
| Phreesia Inc | 0.1% | 1,276,726 | 66.5M USD | −3.0% reduced | Q2 2020 4 quarters |
| Bitcoin Fund/The | < 0.1% | 199,331 | 12.9M USD | −36.4% reduced | Q2 2020 4 quarters |
| Lightspeed POS Inc | < 0.1% | 16,774 | 1.1M USD | −97.5% reduced | Q2 2020 4 quarters |
| Slack Technologies Inc | < 0.1% | 4,735 | 192.0K USD | −99.6% reduced | Q2 2020 4 quarters |
| Organovo Holdings Inc | < 0.1% | 606,221 | 5.8M USD | −56.8% reduced | Q3 2020 3 quarters |
| Biondvax Pharmaceuticals Ltd | < 0.1% | 9,778 | 37.0K USD | −76.5% reduced | Q3 2020 3 quarters |
| HON Honeywell Technologies | < 0.1% | 3,245 | 704.0K USD | −91.3% reduced | Q4 2020 2 quarters |
| GOOGL Alphabet Inc. (Class A) | < 0.1% | 3 | 6.0K USD | −100.0% reduced | Q4 2020 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Technology 7.9%
- Consumer Discretionary 7.8%
- Financials 7.1%
- Health Care 4.8%
- Industrials 1.3%
- Communication Services 0.9%
- Real Estate 0.5%
- not in our coverage 69.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors